Pacific Biosciences Of California (PACB) Net Cash Flow (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Net Cash Flow of -$7.4 million for Q1 2026, down 335.73% year-over-year from $3.1 million in Q1 2025, and down 206.25% quarter-over-quarter from $7.0 million in Q4 2025.
Pacific Biosciences Of California (PACB) Net Cash Flow (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$7.4 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 335.73% year-over-year to -$7.4 million; the TTM figure through Mar 2026 stood at -$2.9 million (up 84.63% YoY), while the FY2025 annual figure was $7.7 million, up 106.13% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$7.4 million, down from $7.0 million in the prior quarter.
- The five-year high for Net Cash Flow was $176.4 million in Q3 2023, with the low at -$205.7 million in Q4 2023.
- The 5-year median for Net Cash Flow is -$6.0 million (2022), against an average of -$24.0 million.
- Peak annual rise in Net Cash Flow reached 3033.48% in 2023, while the deepest fall reached 1096.02% in 2023.
- Pacific Biosciences Of California's Net Cash Flow stood at $20.7 million in 2022, then tumbled by 1096.02% to -$205.7 million in 2023, then jumped by 89.01% to -$22.6 million in 2024, then surged by 130.78% to $7.0 million in 2025, then plunged by 206.25% to -$7.4 million in 2026.
- Business Quant data shows PACB's Net Cash Flow at -$7.4 million in Q1 2026, $7.0 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Pacific Biosciences Of California | 398.57 Mn | 161.70 Mn | 12.64 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.74 Mn |
| Jun 30, 2026 | 4.74 Mn |
| Mar 31, 2026 | -7.40 Mn |
| Mar 31, 2026 | -7.40 Mn |
| Dec 31, 2025 | 6.96 Mn |
| Dec 31, 2025 | 6.96 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | -4.09 Mn |
| Jun 30, 2025 | -4.09 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | -22.61 Mn |
| Dec 31, 2024 | -22.61 Mn |
| Sep 30, 2024 | -21.59 Mn |
| Sep 30, 2024 | -21.59 Mn |
| Jun 30, 2024 | 22.42 Mn |
| Jun 30, 2024 | 22.42 Mn |
| Mar 31, 2024 | -103.27 Mn |
| Mar 31, 2024 | -103.27 Mn |